Literature DB >> 20130239

Leukemogenic transformation by HOXA cluster genes.

Christian Bach1, Sebastian Buhl, Dorothée Mueller, María-Paz García-Cuéllar, Emanuel Maethner, Robert K Slany.   

Abstract

HOX homeobox genes are important regulators of normal and malignant hematopoiesis. Abdominal-type HOXA genes like HOXA9 are highly leukemogenic. However, little is known about transformation by anterior HOXA genes. Here we performed a comprehensive assessment of the oncogenic potential of every HOXA gene in primary hematopoietic cells. With exception of HOXA2 and HOXA5, all HOXA genes caused a block or delay of hematopoietic differentiation and cooperated with Meis1. No evidence for the alleged tumor-suppressor function of HOXA5 could be found. Whereas all active HOXA genes immortalized mixed granulocytic/monocytic populations, HOXA13 preferentially specified monocytoid development. The anterior HOXA genes HOXA1, HOXA4, and HOXA6 transformed cells, generating permanent cell lines, although they did so less potently than HOXA9. Upon transplantation these lines induced myeloproliferation and acute myeloid leukemia in recipient animals. Kinetic studies with inducible HOX derivatives demonstrated that anterior HOXA genes autonomously contributed to cellular transformation. This function was not mediated by endogenous Hoxa9, which was persistently expressed in cells transformed by anterior HOX genes. In summary our results demonstrate a hitherto unexpected role of anterior HOXA genes in hematopoietic malignancy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130239     DOI: 10.1182/blood-2009-04-216606

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  58 in total

1.  Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.

Authors:  Zejuan Li; Hao Huang; Yuanyuan Li; Xi Jiang; Ping Chen; Stephen Arnovitz; Michael D Radmacher; Kati Maharry; Abdel Elkahloun; Xinan Yang; Chunjiang He; Miao He; Zhiyu Zhang; Konstanze Dohner; Mary Beth Neilly; Colles Price; Yves A Lussier; Yanming Zhang; Richard A Larson; Michelle M Le Beau; Michael A Caligiuri; Lars Bullinger; Peter J M Valk; Ruud Delwel; Bob Lowenberg; Paul P Liu; Guido Marcucci; Clara D Bloomfield; Janet D Rowley; Jianjun Chen
Journal:  Blood       Date:  2012-01-17       Impact factor: 22.113

2.  Mechanisms of mixed-lineage leukemia.

Authors:  Andrew G Muntean
Journal:  Int J Hematol Oncol       Date:  2013-06-01

3.  Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.

Authors:  Maria-Paz Garcia-Cuellar; Julia Steger; Elisa Füller; Katrin Hetzner; Robert K Slany
Journal:  Haematologica       Date:  2015-04-24       Impact factor: 9.941

4.  Enforced expression of Hoxa5 in haematopoietic stem cells leads to aberrant erythropoiesis in vivo.

Authors:  Dan Yang; Xiangzhong Zhang; Yong Dong; Xiaofei Liu; Tongjie Wang; Xiaoshan Wang; Yang Geng; Shumin Fang; Yi Zheng; Xiaoli Chen; Jiekai Chen; Guangjin Pan; Jinyong Wang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  Insulin-like growth factor 1 is a direct HOXA9 target important for hematopoietic transformation.

Authors:  J Steger; E Füller; M-P Garcia-Cuellar; K Hetzner; R K Slany
Journal:  Leukemia       Date:  2014-09-25       Impact factor: 11.528

6.  A human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification.

Authors:  Clara Bueno; Rosa Montes; Gustavo J Melen; Verónica Ramos-Mejia; Pedro J Real; Verónica Ayllón; Laura Sanchez; Gertrudis Ligero; Iván Gutierrez-Aranda; Agustín F Fernández; Mario F Fraga; Inmaculada Moreno-Gimeno; Deborah Burks; María del Carmen Plaza-Calonge; Juan C Rodríguez-Manzaneque; Pablo Menendez
Journal:  Cell Res       Date:  2012-01-03       Impact factor: 25.617

7.  The function of homeobox genes and lncRNAs in cancer.

Authors:  Yingchao Wang; Yuan Dang; Jingfeng Liu; Xiaojuan Ouyang
Journal:  Oncol Lett       Date:  2016-07-21       Impact factor: 2.967

8.  MLL is essential for NUP98-HOXA9-induced leukemia.

Authors:  Y Shima; M Yumoto; T Katsumoto; I Kitabayashi
Journal:  Leukemia       Date:  2017-02-17       Impact factor: 11.528

9.  HOXA/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy.

Authors:  Glenda J Dickson; Fabio G Liberante; Laura M Kettyle; Kathleen A O'Hagan; Damian P J Finnegan; Lars Bullinger; Dirk Geerts; Mary Frances McMullin; Terry R J Lappin; Ken I Mills; Alexander Thompson
Journal:  Haematologica       Date:  2013-03-28       Impact factor: 9.941

10.  PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.

Authors:  Zejuan Li; Ping Chen; Rui Su; Chao Hu; Yuanyuan Li; Abdel G Elkahloun; Zhixiang Zuo; Sandeep Gurbuxani; Stephen Arnovitz; Hengyou Weng; Yungui Wang; Shenglai Li; Hao Huang; Mary Beth Neilly; Gang Greg Wang; Xi Jiang; Paul P Liu; Jie Jin; Jianjun Chen
Journal:  Cancer Res       Date:  2016-01-08       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.